Glucocorticoids

Nov 11, 2017 by in RHEUMATOLOGY Comments Off on Glucocorticoids

Glucocorticoids remain part of the treatment strategy in many rheumatic diseases, because of their anti-inflammatory and immunosuppressive actions. Unfortunately, their clinically desired effects are linked to adverse effects, especially at…

read more

Immune modulation of rheumatoid arthritis

Nov 11, 2017 by in RHEUMATOLOGY Comments Off on Immune modulation of rheumatoid arthritis

The approval – several years ago – of the first tumour necrosis factor-α (TNF-α) inhibitor for the management of rheumatoid arthritis launched a new era in the therapeutics of rheumatology….

read more

Spondyloarthritides

Nov 11, 2017 by in RHEUMATOLOGY Comments Off on Spondyloarthritides

The most important clinical features of the spondyloarthritides (SpA) are not only inflammatory back pain (IBP) but also peripheral (enthesitis) and extra-articular symptoms. For clinical purposes, two forms related to…

read more

Biomechanical factors in osteoarthritis

Nov 11, 2017 by in RHEUMATOLOGY Comments Off on Biomechanical factors in osteoarthritis

Biomechanical factors play an important role in the health of diarthrodial joints. Altered joint loading – associated to obesity, malalignment, trauma or joint instability – is a critical risk factor…

read more

Osteoarthritis

Nov 11, 2017 by in RHEUMATOLOGY Comments Off on Osteoarthritis

The pathogenesis of osteoarthritis (OA) appears to be the result of a complex interplay between mechanical, cellular and biochemical forces. Obesity is the strongest risk factor for disease onset in…

read more

Joint appendages – the structures which have historically been overlooked in arthritis research and therapy development

Nov 11, 2017 by in RHEUMATOLOGY Comments Off on Joint appendages – the structures which have historically been overlooked in arthritis research and therapy development

Rheumatologists have largely conceptualised joint disease in inflammatory and degenerative arthritis in terms of bone, cartilage and the synovial lining, but have tended to overlook other integral components of the…

read more

The synovium as a privileged site in rheumatoid arthritis: Cadherin-11 as a dominant player in synovial pathology

Nov 11, 2017 by in RHEUMATOLOGY Comments Off on The synovium as a privileged site in rheumatoid arthritis: Cadherin-11 as a dominant player in synovial pathology

Rheumatoid arthritis is a systemic disease in which an autoimmune response translates primarily into joint inflammation with attendant joint destruction. While evidence implicates both the adaptive and innate immune system…

read more
Get Clinical Tree app for offline access